Northeast Financial Consultants Inc Has $935,000 Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Northeast Financial Consultants Inc reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 1.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 6,810 shares of the financial services provider’s stock after selling 120 shares during the quarter. Northeast Financial Consultants Inc’s holdings in iShares Biotechnology ETF were worth $935,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Williams Financial LLC bought a new stake in iShares Biotechnology ETF in the second quarter valued at approximately $867,000. Mmbg Investment Advisors CO. grew its holdings in shares of iShares Biotechnology ETF by 0.6% in the 4th quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock valued at $10,671,000 after buying an additional 495 shares during the period. Oppenheimer & Co. Inc. increased its position in shares of iShares Biotechnology ETF by 7.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after buying an additional 2,532 shares in the last quarter. Chemistry Wealth Management LLC raised its stake in iShares Biotechnology ETF by 20.6% during the 1st quarter. Chemistry Wealth Management LLC now owns 3,560 shares of the financial services provider’s stock worth $488,000 after buying an additional 609 shares during the period. Finally, Future Financial Wealth Managment LLC bought a new position in iShares Biotechnology ETF during the first quarter worth about $27,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $144.90 on Friday. The business has a 50-day moving average of $145.70 and a two-hundred day moving average of $138.84. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which will be paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th will be issued a dividend of $0.2005 per share. The ex-dividend date of this dividend is Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.